F

Frazier Healthcare Partners

101 employees

Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.

Investor insights

Sectors invested in

Biotechnology143
Health Care119
Therapeutics66
Medical58
Pharmaceutical53
Medical Device45
Biopharma21
Life Science16
Health Diagnostics14
Manufacturing10
Wellness9
Clinical Trials7
oncology6
Healthcare6
Inflammation5
HIV5
Pharmaceuticals5
Immunology5
biotech4
Commercialization4

Funding rounds participated in

$30M sweet spot round size

Most of their 206 investments are in rounds between $15M and $50M

Investor type

Private Equity Firm

Basic info

Industry

venture capital and private equity principals

Sectors

Healthcare Services
Health Care
Medical Products & Distribution
Pharmaceuticals
Venture Capital

Date founded

1991

Investments made

C

CurveBeam raised $25M on January 31, 2023

Investors: Firetrail Investments and Frazier Healthcare Partners

N

NewAmsterdam Pharma raised $235M on November 23, 2022

Investors: Life Sciences Partners (LSP), Forbion, Medicxi, RA Capital Management, L.P., GMT Capital and Frazier Healthcare Partners

P

Pardes Biosciences raised $75M on December 27, 2021

Investors: GMF CAPITAL, Foresite Capital, Monashee Investment Management LLC, Gilead Sciences, RA Capital Management, L.P., T. Rowe Price and Frazier Healthcare Partners

U

Undisclosed raised $40M on November 30, 2021

Investors: Versant Ventures, Samsara BioCapital and Frazier Healthcare Partners

T

Tricida, Inc. raised $42M on November 15, 2021

Investors: OrbiMed Advisors and Frazier Healthcare Partners

S

Silence Therapeutics plc raised $20M on November 5, 2021

Investors: Frazier Healthcare Partners

R

Radionetics Oncology raised $30M on October 18, 2021

Investors: 5AM Ventures and Frazier Healthcare Partners

G

Gritstone bio raised $55M on September 16, 2021

Investors: Redmile Group, Gilead Sciences and Frazier Healthcare Partners

A

Alpine Immune Sciences, Inc. raised $91M on September 15, 2021

Investors: OrbiMed Advisors, Decheng Capital, Logos Global Management, LP, TCG X, Avidity Partners, Omega Funds and Frazier Healthcare Partners

H

HilleVax raised $135M on September 8, 2021

Investors: Greenspring Associates, Qiming Venture Partners USA, Sahsen Ventures, LLC, Richard King Mellon Foundation, Samsara BioCapital, Perceptive Advisors, Lightspeed Venture Partners, RA Capital Management, L.P. and Frazier Healthcare Partners

FAQ